the studies presented herein , assessing host resistance by in vivo tumor challenge and an in vitro growth inhibition assay ( gia ) measuring the effect of splenic lymphocytes on 3h-thymidine incorporation into monolayers of sarcoma cells , revealed an antagonistic relationship between sinecomitant immunity and tumor antigen immunotherapy .
C0020964
immunity
C0003320
antigen